Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue (2018)
- Authors:
- USP affiliated authors: SEELAENDER, MARILIA CERQUEIRA LEITE - ICB ; ROSA NETO, JOSÉ CESAR - ICB
- Unidade: ICB
- DOI: 10.3389/fphar.2018.00452
- Subjects: TECIDO ADIPOSO; METFORMINA; GLICOSE; QUIMIOTERAPIA; CAMUNDONGOS; INSULINA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 9, p. 1-10, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BIONDO, Luana A. et al. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue. Frontiers in Pharmacology, v. 9, p. 1-10, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00452. Acesso em: 27 set. 2024. -
APA
Biondo, L. A., Batatinha, H. A., Souza, C. O. de, Teixeira, A. A. de S., Silveira, L. S., Alonso-Vale, M. I., et al. (2018). Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue. Frontiers in Pharmacology, 9, 1-10. doi:10.3389/fphar.2018.00452 -
NLM
Biondo LA, Batatinha HA, Souza CO de, Teixeira AA de S, Silveira LS, Alonso-Vale MI, Oyama LM, Alves MJ, Seelaender MCL, Rosa Neto JC. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-10.[citado 2024 set. 27 ] Available from: https://doi.org/10.3389/fphar.2018.00452 -
Vancouver
Biondo LA, Batatinha HA, Souza CO de, Teixeira AA de S, Silveira LS, Alonso-Vale MI, Oyama LM, Alves MJ, Seelaender MCL, Rosa Neto JC. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-10.[citado 2024 set. 27 ] Available from: https://doi.org/10.3389/fphar.2018.00452 - Inflammation in the disease: Mechanism and therapies 2014
- Costly immunometabolic remodeling in disused muscle buildup through physical exercise
- The therapeutic potential of exercise to treat cachexia
- Modulatory effects of physical activity levels on immune responses and general clinical functions in adult patients with mild to moderate SARS-CoV-2 infections—a protocol for an observational prospective follow-Up investigation: Fit-COVID-19 Study
- Mild to moderate post-COVID-19 alters markers of lymphocyte activation, exhaustion, and immunometabolic responses that can be partially associated by physical activity level- an observational sub-analysis fit- COVID study
- Impact of doxorubicin treatment on the physiological functions of white adipose tissue
- Importância dos efeitos fisiológicos do exercício na promoção da saúde
- Palmitoleic acid improves metabolic functions in fatty liver by PPARα-dependent AMPK activation
- Acerola (Malpighia emarginata DC.) juice intake protects against alterations to proteins involved in inflammatory and lipolysis pathways in the adipose tissue of obese mice fed a cafeteria diet
- Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR-α Knockout Mice
Informações sobre o DOI: 10.3389/fphar.2018.00452 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
